STOCK TITAN

Director Lu Richard Yuqiang reports insider status at Starlink AI (OTAI)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Starlink AI Acquisition Corp filed an initial insider ownership report for director Lu Richard Yuqiang. The filing does not list any common stock or derivative holdings for him at this time, and it shows no reported purchases, sales, exercises, gifts, or other transactions.

Positive

  • None.

Negative

  • None.
reportingPersons financial
""reportingPersons": [ { "name": "Lu Richard Yuqiang" } ]"
transactionSummary financial
""transactionSummary": { "buyCount": 0, "sellCount": 0 }"
derivativeSummary financial
""derivativeSummary": []"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Lu Richard Yuqiang

(Last)(First)(Middle)
605W W 42ND STREET

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
05/07/2026
3. Issuer Name and Ticker or Trading Symbol
Starlink AI Acquisition Corp [ OTAI ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Lu Richard Yuqiang05/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

Does the OTAI Form 3 for Lu Richard Yuqiang report any stock purchases or sales?

No, the summary shows zero purchases and zero sales for Lu Richard Yuqiang. The transaction counts and share totals for buying, selling, exercising, gifts, tax withholding, and restructuring are all listed as zero in this filing.

Are there any derivative securities reported for Lu Richard Yuqiang in the OTAI Form 3?

No derivative securities are reported for Lu Richard Yuqiang. The derivativeSummary section is empty, and the filing shows a derivative transaction count of zero, indicating no options, warrants, or similar instruments disclosed in this data excerpt.